Emerging Research in Lymphoma and Myeloma

Join us as we speak to Dr. Peter Riedell and Dr. Benjamin Derman from University of Chicago Medicine, about the latest research coming out of the annual meeting of the American Society of Hematology (ASH). In this episode, we discuss new treatments on the horizon for lymphoma and myeloma. The doctors share how innovative therapies such as CAR T-cell therapy and new combinations of medicines are showing significant promise, providing further hope to patients.

CLICK HERE to participate in our episode survey.

Mentioned on this episode: 

Additional LLS Support Resources: 

Support for this episode is provided by University of Chicago Medicine.


  1. This information was very helpful to me, it is offering promise that better treatment and approaches to different therapies are leading to progress in treating this disease.

  2. Thank you. I am in the six year of treatment for MCL The thought that using newer Measurable Residual Disease tests instead of PET scans or even someday being able to possibly stop treatment altogether and still live is beyond encouraging. I will share the link with my doctor.

  3. My husband didnā€™t live to see this. This is the last website is was on probably searching for a cure for the MM.Thank you.

Leave a Comment

Your email address will not be published. Required fields are marked *